• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. SFX SYM PDS+ UNI VIO 18IN 1 S/A CTB-1; SUTURE, SURGICAL, ABSORBABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. SFX SYM PDS+ UNI VIO 18IN 1 S/A CTB-1; SUTURE, SURGICAL, ABSORBABLE Back to Search Results
Model Number SXPP1A301
Device Problems Material Frayed (1262); Material Separation (1562)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 06/30/2023
Event Type  malfunction  
Manufacturer Narrative
Product complaint(b)(4).Additional information: h6 component code: g07002 - device not returned.Additional information has been requested however not received.If further details are received at a later date a supplemental medwatch will be sent.Please clarify when the event occurred? 2.How the procedure was completed.3.Was there any adverse consequence associated with the patient? 4.Name of the procedure? 5.Please provide procedure date.6.Status of product return.The event displays lot: shmhla but the ip displays lot: shmbpb.Please advise which is the correct lot? a manufacturing record evaluation was performed for the finished device batch, and no non-conformances were identified.This is a combination product, and the event has been reviewed for both the suture and the triclosan.Trade name - irgacare®.Active ingredient(s) ¿ triclosan.Dosage form ¿ suture/solid/parenteral.Strength ¿ = 2360 g/m.This report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Event Description
It was reported a patient underwent a discectomy on (b)(6) 2023 and barbed suture was used.While closing the wound and the needle snapped from the suture.No adverse consequences were reported.Additional information has been requested.
 
Manufacturer Narrative
Product complaint # (b)(4).Date sent to the fda: 9/20/2023.This report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Additional information was requested, the following was obtained: it did not break but started getting thinner and thinner, making surgeon afraid to use it.
 
Manufacturer Narrative
Product complaint # (b)(4).Additional information: d 9.Date device returned to manufacturer, d 9.Is device returned to manufacturer? additional information was requested, and the following was obtained: 1.Please clarify when the event occurred? (b)(6) 2023.2.Please provide procedure date? (b)(6) 2023.The following information was requested, but unavailable: 1.How the procedure was completed 2.Was there any adverse consequence associated with the patient? 3.Name of the procedure? attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.Based on the previous response the correct lot for this event is from the event description, shmhla.However, samples from lot shmbpb were returned for evaluation.Please clarify if there was any quality issue with the sutures returned from lot shmbpb.Investigation summary: the product was returned to ethicon for evaluation.Visual inspection and functional testing were conducted on the returned device.The returned sample determined that seven unopened samples that pertain to the product code sxpp1a301 were received.In order to evaluate the condition of the returned samples, the packets were opened.The swage and attachment area was noted to be as expected.The sutures were dispensed without problems and examined along the strand no anomalies were observed during the evaluation.A functional test was performed using instron equipment and the pull force result was above the minimum requirements.As part of the ethicon quality process, all devices are manufactured, inspected, and released to approved specifications.A manufacturing record evaluation was performed for the finished device lot, and no non-conformances were identified.This report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Corrected information: d 4.Lot, d 4.Expiration date, d 9.Device available for evaluation?, h3.Device evaluated by manufacturer?, h4.Device manufacture date, h6.Medical device problem code, h6.Component code, h6.Type of investigation, h6.Investigation findings, h6.Investigation conclusions.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SFX SYM PDS+ UNI VIO 18IN 1 S/A CTB-1
Type of Device
SUTURE, SURGICAL, ABSORBABLE
Manufacturer (Section D)
ETHICON INC.
1000 route 202
raritan NJ 08869
Manufacturer (Section G)
ETHICON INC.-JUAREZ
avenida de las torres 7125,
col salvacar
ciudad juarez 32604
MX   32604
Manufacturer Contact
elba bello
1000 route 202
raritan, NJ 08869
9083863534
MDR Report Key17374925
MDR Text Key320076239
Report Number2210968-2023-05302
Device Sequence Number1
Product Code NEW
UDI-Device Identifier10705031227712
UDI-Public10705031227712
Combination Product (y/n)Y
Reporter Country CodeUK
PMA/PMN Number
K113004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other
Type of Report Initial,Followup,Followup,Followup
Report Date 09/20/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/21/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberSXPP1A301
Device Catalogue NumberSXPP1A301
Device Lot NumberSHMBPB
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Date Manufacturer Received08/31/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/06/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-